IDXX – IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.IDXX
$574.00Name : IDEXX Laboratories, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $45,704,196,096.00
EPSttm : 13.09
IDEXX Laboratories, Inc.
$574.00
1.95%$11.00
IDXX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.43
Margin Of Safety %
-4
Put/Call OI Ratio
0.72
EPS Next Q Diff
0.86
EPS Last/This Y
1.34
EPS This/Next Y
1.88
Price
574.21
Target Price
761.08
Analyst Recom
1.82
Performance Q
-19.53
Upside
-49.9%
Beta
1.69
Ticker: IDXX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-17 | IDXX | 587.08 | 0.86 | 0.16 | 3196 |
| 2026-03-18 | IDXX | 576.94 | 0.85 | 2.06 | 3220 |
| 2026-03-19 | IDXX | 580.01 | 0.84 | 14.71 | 3213 |
| 2026-03-20 | IDXX | 576.98 | 0.84 | 2.44 | 3221 |
| 2026-03-23 | IDXX | 578.82 | 0.73 | 0.11 | 2587 |
| 2026-03-24 | IDXX | 570.5 | 0.72 | 2.52 | 2612 |
| 2026-03-25 | IDXX | 575.58 | 0.73 | 1.30 | 2656 |
| 2026-03-26 | IDXX | 573.35 | 0.73 | 4.38 | 2684 |
| 2026-03-27 | IDXX | 559.32 | 0.73 | 2.44 | 2712 |
| 2026-03-30 | IDXX | 558.09 | 0.72 | 0.23 | 2746 |
| 2026-03-31 | IDXX | 561.72 | 0.70 | 4.42 | 2768 |
| 2026-04-01 | IDXX | 564.47 | 0.72 | 0.90 | 2808 |
| 2026-04-02 | IDXX | 569.46 | 0.71 | 0.43 | 2827 |
| 2026-04-06 | IDXX | 577.61 | 0.71 | 0.13 | 2836 |
| 2026-04-08 | IDXX | 591.79 | 0.70 | 0.69 | 2862 |
| 2026-04-09 | IDXX | 584.88 | 0.70 | 10.67 | 2869 |
| 2026-04-13 | IDXX | 573.96 | 0.72 | 3.40 | 2906 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-17 | IDXX | 587.51 | 15.8 | 112.6 | 14.51 |
| 2026-03-18 | IDXX | 576.91 | 15.8 | 84.9 | 14.51 |
| 2026-03-19 | IDXX | 580.01 | 15.8 | 107.1 | 14.51 |
| 2026-03-20 | IDXX | 577.26 | 15.8 | 93.5 | 14.51 |
| 2026-03-23 | IDXX | 578.53 | 15.8 | 103.1 | 14.51 |
| 2026-03-24 | IDXX | 570.18 | 15.8 | 79.2 | 14.51 |
| 2026-03-25 | IDXX | 575.53 | 15.8 | 113.3 | 14.51 |
| 2026-03-26 | IDXX | 573.24 | 15.8 | 93.7 | 14.51 |
| 2026-03-27 | IDXX | 558.19 | 15.8 | 62.0 | 14.51 |
| 2026-03-30 | IDXX | 557.07 | 15.8 | 96.7 | 14.51 |
| 2026-03-31 | IDXX | 561.81 | 15.8 | 112.1 | 14.51 |
| 2026-04-01 | IDXX | 564.40 | 15.8 | 106.3 | 14.51 |
| 2026-04-02 | IDXX | 569.47 | 15.8 | 112.1 | 14.51 |
| 2026-04-06 | IDXX | 577.73 | 15.8 | 120.6 | 14.51 |
| 2026-04-07 | IDXX | 574.84 | 15.8 | 92.7 | 14.51 |
| 2026-04-09 | IDXX | 584.75 | 15.8 | 82.7 | 14.51 |
| 2026-04-10 | IDXX | 563.00 | 15.4 | 46.4 | 14.51 |
| 2026-04-13 | IDXX | 574.21 | 15.4 | 128.5 | 14.51 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-17 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-18 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-19 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-20 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-23 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-24 | IDXX | -5.90 | -0.30 | 2.22 |
| 2026-03-25 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-03-26 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-03-27 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-03-30 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-03-31 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-04-01 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-04-02 | IDXX | -5.90 | -0.30 | 2.29 |
| 2026-04-06 | IDXX | -5.90 | -0.25 | 2.29 |
| 2026-04-07 | IDXX | -5.90 | -0.25 | 2.29 |
| 2026-04-08 | IDXX | -5.90 | -0.25 | 2.29 |
| 2026-04-09 | IDXX | -5.90 | -0.25 | 2.29 |
| 2026-04-10 | IDXX | -5.90 | -0.25 | 2.29 |
| 2026-04-13 | IDXX | -5.91 | -0.31 | 2.43 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.08
Avg. EPS Est. Current Quarter
3.43
Avg. EPS Est. Next Quarter
3.94
Insider Transactions
-5.91
Institutional Transactions
-0.31
Beta
1.69
Average Sales Estimate Current Quarter
1120
Average Sales Estimate Next Quarter
1199
Fair Value
552.17
Quality Score
98
Growth Score
95
Sentiment Score
50
Actual DrawDown %
25.4
Max Drawdown 5-Year %
-54
Target Price
761.08
P/E
43.88
Forward P/E
34.87
PEG
2.73
P/S
10.59
P/B
28.5
P/Free Cash Flow
43.28
EPS
13.08
Average EPS Est. Cur. Y
14.51
EPS Next Y. (Est.)
16.39
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
24.62
Relative Volume
0.88
Return on Equity vs Sector %
38.7
Return on Equity vs Industry %
55.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
128.5
◆
IDXX
Healthcare
$574.00
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.6
Range 1M
43.3%
Sup Dist
3.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
11%
EPS NY
13.3%
52W%
48.1%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-13.2% upside
Upside
-13.2%
Quality
98
MoS
-4%
IDEXX Laboratories, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 11000
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDXX
Latest News
—
Caricamento notizie per IDXX…
stock quote shares IDXX – IDEXX Laboratories, Inc. Stock Price stock today
news today IDXX – IDEXX Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IDXX – IDEXX Laboratories, Inc. yahoo finance google finance
stock history IDXX – IDEXX Laboratories, Inc. invest stock market
stock prices IDXX premarket after hours
ticker IDXX fair value insiders trading